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Tau is a microtubule-associated protein that is abundant
in the central nervous system and expressed mainly in
axons. Tau hyperphosphorylation can induce its aggrega-
tion, and is thought to induce neurofibrillary tangles for-
mation in Alzheimer’s disease (AD) and other tauopathies.
Understanding the causes and consequences of tau pathol-
ogy is important because it shows a strong relationship to
dementia in AD, and to memory loss in normal aging and
mild cognitive impairment.
The causes of sporadic AD are likely to be multifactorial,
with external and biological factors interacting with
genetic susceptibilities to accelerate the manifestation of
the disease. Diabetes and obesity might be such accelerat-
ing factors since both are independently linked to cogni-
tive decline, and since diabetes has been shown to increase
the risk of AD. It has been suggested that the effects of
diabetes and obesity on AD pathogenesis might be
mediated by the concommitant insulin resistance that can
be present in both medical conditions. However, recent
data data suggest that obesity could accelerate tau path-
ology in the absence of insulin resistance.
To address this controversy, we used genetic models of
diabetes and obesity (db/db mice and ob/ob mice) that
present different degrees of insulin resistance. We found
that both db/db and ob/ob mice had tau hyperphosphory-
lation, but also mild hypothermia, which is a powerful pro-
moter of tau hyperphosphorylation. Maintaining the mice
normothermic resulted in total rescue of tau phosphory-
lation in db/db mice, but not in ob/ob mice.
Our results suggest that insulin resistance induces tau
hyperphosphorylation through hypothermia in both
mouse models, but that ob/ob mice have additional
upregulation of tau phosphorylation independant of
temperature and insulin resistance.
This research will help understanding the link between
diabetes, obesity and AD, and the development of future
treatments or life style strategies destined to check the
advance of the disease.
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